Allan Reine - Chief Executive Officer, Director at Prime Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
PRME on Nasdaq
All Insider Reports
All Insider Reports

Allan Reine - trading volume in the past year for Prime Medicine, Inc.

Holdings reported by Allan Reine for Prime Medicine, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 125,000 $147,150 $1.18 21 May 2025 Direct
Stock Option (right to buy) 850,000 01 Aug 2025 Direct Common Stock

Transactions reported by Allan Reine for Prime Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.